Suchergebnisse - "Lenalidomide"

PubPharm (5.975)

31

Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy : A Single Center Database Review in Greece

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Kastritis, E. | Ntanasis-Stathopoulos, I. | Theodorakakou, F. | +14

32

Safety and Effectiveness of Elotuzumab in Japanese Patients with Relapsed/Refractory Multiple Myeloma : A Post-marketing Surveillance Study

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Kaneko, F. | Suzuka, H. | Yoshino, T. | +1

33

An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd) : SELECT study

enthalten in: Leukemia & lymphoma | 2024

von Perrot, A. | Delimpasi, S. | Spanoudakis, E. | +8

34

Treatment-emergent mutations in myelodysplastic syndrome with del(5q) - lenalidomide related or disease-intrinsic clonal evolution?

enthalten in: Blood cancer journal | 2024

von Abdallah, M. | Reichard, K. | Gangat, N. | +1

35

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma : An open label, phase 2 study

enthalten in: Cancer | 2024

von Gordon, M. | Feng, L. | Strati, P. | +20

36

Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7

enthalten in: Leukemia | 2024

von Kann, M. | Schneider, E. | Almazan, A. | +10

37

Combining lenalidomide with erythropoiesis stimulating agents : a party of one

enthalten in: Leukemia | 2024

von Chandhok, N. | Sekeres, M.

38

Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden : An analysis using linked Nordic registries

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Abildgaard, N. | Anttila, P. | Waage, A. | +7

39

Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic stem cell transplantation

enthalten in: Heliyon | 2024

von Tyrinova, T. | Batorov, E. | Aristova, T. | +4

40

An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Yu, Y. | Tian, W. | Grauffel, C. | +9